Opportunities Preloader

Please Wait.....

Report

Self-Monitoring Blood Glucose Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

Market Report I 2025-02-17 I 132 Pages I Global Market Insights

The Global Self-Monitoring Blood Glucose Devices Market was valued at USD 19.8 billion in 2024 and is projected to expand at a CAGR of 11.8% from 2025 to 2034. The increasing prevalence of diabetes worldwide is the primary driver of market growth, with millions of individuals requiring continuous glucose monitoring for effective disease management. Governments and healthcare organizations are intensifying efforts to raise awareness about diabetes, promoting early detection and encouraging the adoption of SMBG devices. In the European Union, targeted screening programs are designed for high-risk populations, leading to a growing demand for diabetes-related treatments. The need for frequent blood sugar monitoring, particularly among individuals diagnosed with type 1 and type 2 diabetes, further accelerates market expansion. Continuous improvements in device accuracy and ease of use are enhancing their adoption among both patients and healthcare providers.

The market is segmented based on product, application, and end use. By product, the SMBG devices market is divided into self-monitoring blood glucose meters and consumables. The consumables segment led the market, generating USD 11.1 billion in 2024. These devices rely on consumable components such as test strips and lancets, which are critical for daily glucose monitoring. Test strips, designed for single use, remain the most in-demand component due to their compact size and convenience. The accuracy of these strips significantly impacts diabetes management, with modern versions delivering precise readings when used with compatible glucose meters. Manufacturers are also refining lancet designs to make blood sampling less painful, enhancing user comfort and encouraging frequent glucose monitoring.

By application, the SMBG devices market is categorized into type 1 diabetes, type 2 diabetes, and gestational diabetes. Type 2 diabetes accounted for the largest revenue share, representing 69.3% of the market in 2024, and is projected to reach USD 41.6 billion by 2034. The growing prevalence of type 2 diabetes is a key factor behind its market dominance, as individuals with this condition experience impaired insulin production and reduced cellular response to insulin. The rising incidence of lifestyle-related risk factors, such as obesity and sedentary habits, further contributes to the increasing demand for SMBG devices in this segment.

By end use, the SMBG devices market is segmented into hospitals, ambulatory surgery centers, diagnostic centers, home care, and other users. Homecare emerged as the largest segment, holding 37.7% of the market share in 2024. The ability to monitor blood glucose levels independently reduces the need for frequent clinical visits, particularly benefiting elderly patients and those with mobility challenges. The widespread use of these devices at home allows individuals to make real-time adjustments to their diet, exercise, and medication routines, leading to improved diabetes management.

In the United States, the SMBG devices market was valued at USD 6.4 billion in 2023 and is expected to reach USD 20.3 billion by 2034. The country faces a significant economic burden due to diabetes, with healthcare costs associated with the disease exceeding USD 412.9 billion in 2022, a sharp increase from USD 327 billion in 2017. The high healthcare spending in the U.S. fosters the widespread adoption of SMBG devices, encouraging innovation and advanced diabetes management solutions.

Report Content
Chapter 1 Methodology and Scope
1.1 Market scope and definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates and calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 360synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of diabetes worldwide
3.2.1.2 Government initiatives for increasing awareness among people
3.2.1.3 Technological advancements in developed countries
3.2.2 Industry pitfalls and challenges
3.2.2.1 High cost of advanced devices and accessories in developing countries
3.2.2.2 Stringent regulatory requirements
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Future market trends
3.6 Technology landscape
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2024
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)
5.1 Key trends
5.2 Self-monitoring blood glucose meters
5.3 Consumables
5.3.1 Testing strips
5.3.2 Lancets
Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)
6.1 Key trends
6.2 Type 1 diabetes
6.3 Type 2 diabetes
6.4 Gestational diabetes
Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)
7.1 Key trends
7.2 Hospitals
7.3 Ambulatory Surgery Centers (ASCs)
7.4 Diagnostic centers
7.5 Home care
7.6 Other end use
Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.4 Asia Pacific
8.4.1 China
8.4.2 India
8.4.3 Japan
8.4.4 Australia
8.4.5 South Korea
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.6 Middle East and Africa
8.6.1 Saudi Arabia
8.6.2 South Africa
8.6.3 UAE
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 AgaMatrix
9.3 All Medicus
9.4 Arkray
9.5 Ascensia Diabetes Care Holdings
9.6 B. Braun Melsungen
9.7 Bionime Corporation
9.8 DarioHealth
9.9 F. Hoffmann-La Roche
9.10 LifeScan
9.11 Nova Biomedical
9.12 Omnis Health
9.13 Sanofi
9.14 Sinocare
9.15 Ypsomed Holding

  • Not Sure / Need Reassuring
    • Confirm Content
      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages
      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives
      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices
      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts
      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies
      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses
      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License
      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats
      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery
      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges
      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card
      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer
      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security
      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security
      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE